Form 4: Longeveron CEO Awarded Significant Equity Compensation

Longeveron Inc.'s Chief Executive Officer, Mohamed Wa'el Ahmed Hashad, was granted 180,000 Restricted Stock Units and options to purchase 60,000 shares of Class A Common Stock.

Summary

• Mohamed Wa'el Ahmed Hashad, the Chief Executive Officer of Longeveron Inc. (LGVN), was the reporting person for this transaction.
• On July 15, 2025, the CEO acquired 180,000 shares of Class A Common Stock in the form of time-based vesting Restricted Stock Units (RSUs).
• Following this transaction, the CEO beneficially owns 420,904 shares of Class A Common Stock, which includes RSUs subject to future vesting.
• The CEO also acquired options to purchase 60,000 shares of Class A Common Stock with an exercise price of $1.47.
• These stock options will vest quarterly over a three-year period, commencing on October 1, 2025.
• The stock options have an expiration date of July 15, 2035.

Sentiment

Score: 7

Explanation: The grant of equity compensation to the CEO is generally positive as it aligns management's interests with shareholders, but it is a routine disclosure and does not indicate significant new operational news or financial performance.

Positives

• The award of significant equity compensation, including 180,000 Restricted Stock Units and options for 60,000 shares, aligns the Chief Executive Officer's financial interests with those of the shareholders.
• The specified stock option exercise price of $1.47 provides a clear benchmark for future stock performance, incentivizing the CEO to drive share price appreciation.

Future Outlook

The stock options granted to the CEO will vest quarterly over a three-year period beginning October 1, 2025, and are exercisable until July 15, 2035.

Industry Context

The granting of equity compensation, such as Restricted Stock Units and stock options, to executive officers is a standard and widely adopted practice across publicly traded companies. This approach is commonly used to incentivize long-term performance, align management's interests with shareholder value creation, and aid in executive retention within the competitive landscape.

Comparison to Industry Standards

• Granting equity awards like RSUs and stock options to executive leadership is a common compensation strategy across various industries, including biotechnology and healthcare, where Longeveron operates. This practice is consistent with global benchmarks for executive incentive programs.
• The specific volume of shares and options awarded would typically be benchmarked against peer companies of similar market capitalization, stage of development, and industry sector. Without specific peer group data or Longeveron's compensation philosophy, a direct quantitative comparison to specific companies or projects is not feasible from this document alone, but the *type* of compensation is standard.

Related Party Transactions

• The award of 180,000 Restricted Stock Units and options to purchase 60,000 shares of Class A Common Stock to Mohamed Wa'el Ahmed Hashad, the Chief Executive Officer, constitutes a related party transaction.

Stakeholder Impact

• Shareholders: The equity awards are intended to align the CEO's long-term interests with shareholder value creation, potentially leading to improved company performance. However, the future vesting and exercise of these awards could result in minor share dilution.
• Employees: No direct impact on general employees is indicated in this filing.
• Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated in this filing.

Next Steps

• Quarterly vesting of the granted stock options will commence on October 1, 2025, and continue over a three-year period.
• The CEO may exercise the stock options at any time between their vesting dates and the expiration date of July 15, 2035.

Key Dates

Keywords

Longeveron Inc., LGVN, SEC Form 4, Insider Transaction, Restricted Stock Units, RSUs, Stock Options, Equity Compensation, CEO Compensation, Beneficial Ownership